Cam Gallagher - 29 Dec 2025 Form 4 Insider Report for Opus Genetics, Inc. (IRD)

Role
Director
Signature
/s/ Amy Rabourn, by Power of Attorney
Issuer symbol
IRD
Transactions as of
29 Dec 2025
Net transactions value
+$323,693
Form type
4
Filing time
31 Dec 2025, 16:33:33 UTC
Previous filing
27 Aug 2025
Next filing
08 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gallagher Cam Director C/O OPUS GENETICS, INC., 8 DAVIS DRIVE, SUITE 220, DURHAM /s/ Amy Rabourn, by Power of Attorney 31 Dec 2025 0001557832

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRD Common Stock Purchase $160,275 +81,000 +4.5% $1.98 1,891,430 29 Dec 2025 Direct F1
transaction IRD Common Stock Purchase $163,419 +83,000 $1.97 83,000 29 Dec 2025 By Garret Gallagher - Custodian UTMA/UGMA F2, F3
transaction IRD Common Stock Award $0 +33,000 +1.7% $0.000000 1,924,430 31 Dec 2025 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.945 to $1.98, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.9476 to $1.98, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 These securities are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F4 Represents a grant of restricted stock units ("RSUs") which vest on December 29, 2026, subject to the Reporting Person's continuing service through the vesting date.
F5 On December 31, 2025, the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 6, 2026, of an additional 67,000 RSUs which vest on December 29, 2026, subject to the Reporting Person's continuing service through the vesting date.